Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
KAYA

Kaya Share Price

 

 

Kaya live price: ₹242.75. It opened at ₹252 vs previous close ₹248; intraday high/low: ₹253/₹242. The 50 & 200 DMA stand at ₹272.10/₹331.90.

Kaya Performance

  • Today's Low
  • ₹242
  • Today's High
  • ₹253
  • 52 Week Low
  • ₹228
  • 52 Week High
  • ₹488
  • Open Price₹252
  • Previous Close₹248
  • Volume19,004
  • 50 DMA₹272.10
  • 100 DMA₹301.86
  • 200 DMA₹331.90

Kaya Chart

Investment Returns

  • Over 1 Month -12.69%
  • Over 3 Month -26.48%
  • Over 6 Month -36.75%
  • Over 1 Year -27.81%

Smart Investing Starts Here Start SIP with Kaya for Steady Growth!

Invest Now

Kaya Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -3.8
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 369
  • P/B Ratio
  • -2.9
  • Average True Range
  • 12.22
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -8.29
  • RSI
  • 37.67
  • MFI
  • 68.55

Latest Stock News Updates

Skin care specialist Kaya Ltd acquires 75% stake in two UAE firms

The company has acquired 75 percent stake in Minal Medical Centre, Dubai, and Minal Specialized Clinic Dermatology, Sharjah

Kaya raises stake in Iris Medical Centre LLC

Skin care firm Kaya Ltd today said it along with a local partner has increased stake in Abu Dhabi-based Iris Medical Centre LLC to 85 per cent by acquiring 10 per cent additional stake for an undisclosed sum

Kaya Limited

Kaya has informed the exchanges that Kaya Middle East, DMCC, a foreign subsidiary of the company, has entered into a joint venture agreement with Al Beda Medical Services KSCC, Kuwait, to set up and o...

Kaya Financials

Kaya Technicals

EMA & SMA

Current Price
₹242.75
-5.6 (-2.25%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹253.03
  • 50 Day
  • ₹272.10
  • 100 Day
  • ₹301.86
  • 200 Day
  • ₹331.90

Resistance and Support

245.82 Pivot Speed
  • R3 261.83
  • R2 257.52
  • R1 250.13
  • S1 238.43
  • S2 234.12
  • S3 226.73

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kaya has an operating revenue of Rs. 222.48 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of -43% needs improvement, NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 9 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 107 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kaya Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-20 Audited Results
2026-01-28 Quarterly Results
2025-11-13 Quarterly Results
2025-09-18 To consider Fund Raising
2025-08-05 Quarterly Results

Kaya Shareholding Pattern

51.43%
0.68%
0%
22.48%
25.41%

Kaya FAQs

Kaya share price is ₹242 As on 22 May, 2026 | 18:56

The Market Cap of Kaya is ₹368.7 Cr As on 22 May, 2026 | 18:56

The P/E ratio of Kaya is -3.8 As on 22 May, 2026 | 18:56

The PB ratio of Kaya is -2.9 As on 22 May, 2026 | 18:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23